UBS (Lux) Equity Fund - Biotech (USD) Q-accRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/03/2024 |
|
Annual Returns (GBP) | 31/03/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |
Price Return | 15.76 | -5.62 | 22.63 | 22.00 | -3.78 | 4.30 | -3.30 | -0.65 |
+/- Category | 5.47 | 2.34 | 2.43 | -3.97 | 5.26 | 12.13 | -2.02 | -2.95 |
+/- Category Index | 0.57 | -3.77 | 5.92 | -10.93 | -4.08 | 1.83 | -10.64 | -9.14 |
% Rank in Category | 24 | 35 | 41 | 41 | 50 | 20 | 54 | 78 |
Trailing Returns (GBP) | 25/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -2.14 | -1.91 | -3.25 |
1 Week | 0.10 | -0.15 | -1.84 |
1 Month | -7.17 | -0.39 | -4.38 |
3 Months | -8.19 | -4.85 | -14.01 |
6 Months | 4.52 | -8.81 | -10.48 |
YTD | -8.84 | -3.73 | -14.76 |
1 Year | -6.44 | -7.00 | -19.40 |
3 Years Annualised | -1.92 | 4.00 | -8.02 |
5 Years Annualised | 3.92 | -1.01 | -7.61 |
10 Years Annualised | 9.25 | 0.34 | -2.49 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | -0.65 | - | - | - |
2023 | -6.39 | -3.59 | 0.72 | 6.37 |
2022 | -7.72 | -0.37 | 15.24 | -1.56 |
2021 | -7.62 | 9.98 | -0.41 | -4.89 |
2020 | -4.02 | 30.70 | -7.63 | 5.28 |
2019 | 14.38 | 0.23 | -6.45 | 14.35 |
|
Advertisement |